accreditation statistics

As of April 6, 2022

Cellular Therapy Entities

  • Accredited: 246
  • Applicants: 19

Cord Blood Banks

  • Accredited: 56
  • Applicants: 7

Congratulations to the following organizations for achieving their initial accreditations: South Texas Blood & Tissue Center (Collections at BioBridge Global Campus), San Antonio, Texas and University of California, Irvine (UCI), Orange, California.

A complete list of accredited organizations can be found at www.factwebsite.org.

U.S. Food and Drug Administration Publishes Updated Donor Eligibility Information Amid COVID-19

Posted in :: 2021 Volume 1 :: Friday, January 29th, 2021

The U.S. Food and Drug Administration (FDA) continues to provide updates regarding donor eligibility determination amid the COVID-19 pandemic. In January, it posted an announcement with information about considerations for donor eligibility and vaccines.

The FDA does not recommend testing asymptomatic donors of human cells, tissues, and cell and tissue based products (HCT/Ps), but does offer considerations for donor screening based on information known at this time. HCT/P establishments may wish to consider whether the donor in the 28 days prior to collection:

  • cared for, lived with, or otherwise had close contact with individuals diagnosed with or suspected of having COVID-19 infection; or
  • had been diagnosed with or suspected of having COVID-19 infection; or
  • had a positive diagnostic test (e.g., nasopharyngeal swab) for SARS-CoV-2 but never developed symptoms.

The FDA also states that, based on information available at this time, donors who have received non-replicating, inactivated, or RNA-based COVID-19 vaccines are not precluded from donating HCT/Ps.

Read the full announcement